122 related articles for article (PubMed ID: 3356206)
21. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
[TBL] [Abstract][Full Text] [Related]
23. Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype.
Lauria F; Raspadori D; Foa R; Zinzani PL; Buzzi M; Gugliotta L; Macchi S; Tura S
Cancer; 1990 May; 65(10):2233-6. PubMed ID: 1693308
[TBL] [Abstract][Full Text] [Related]
24. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
[TBL] [Abstract][Full Text] [Related]
25. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
[TBL] [Abstract][Full Text] [Related]
26. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
Seymour JF; Estey EH; Keating MJ; Kurzrock R
Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
[TBL] [Abstract][Full Text] [Related]
27. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
[TBL] [Abstract][Full Text] [Related]
28. Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia.
Liberati AM; Fizzotti M; Di Clemente F; Senatore M; Berruto P; Falini B; Martelli MF; Grignani F
Leuk Res; 1990; 14(9):779-84. PubMed ID: 2232850
[TBL] [Abstract][Full Text] [Related]
29. Interferon in the treatment of hairy cell leukemia.
Thompson JA; Fefer A
Cancer; 1987 Feb; 59(3 Suppl):605-9. PubMed ID: 3542183
[TBL] [Abstract][Full Text] [Related]
30. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results.
Foon KA; Maluish AE; Abrams PG; Wrightington S; Stevenson HC; Alarif A; Fer MF; Overton WR; Poole M; Schnipper EF
Am J Med; 1986 Mar; 80(3):351-6. PubMed ID: 3953613
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of hairy-cell leukemia using interferon alfa].
Neuwirtová R; Cermák J; Kvasnicka J; Sedlácková M
Cas Lek Cesk; 1989 Aug; 128(34):1065-70. PubMed ID: 2790914
[TBL] [Abstract][Full Text] [Related]
32. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
33. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
[TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia: preliminary results with alpha 2 (r) interferon.
Mandelli F; Annino L; Cafolla A; De Rossi G; Bianco P; Fontana L; Dianzani F
Tumori; 1986 Apr; 72(2):153-6. PubMed ID: 3705188
[TBL] [Abstract][Full Text] [Related]
35. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
36. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
37. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
[TBL] [Abstract][Full Text] [Related]
38. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
39. Hairy cell leukemia: an interferon deficient disease?
Hofmann V; Fehr J; Sauter C; Ottino J
Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
[TBL] [Abstract][Full Text] [Related]
40. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
